US 10975124
Methods and compositions for treating diseases and conditions associated with gonadotropin releasing hormone receptor
granted A61KA61K38/00A61P
Quick answer
US patent 10975124 (Methods and compositions for treating diseases and conditions associated with gonadotropin releasing hormone receptor) held by The Board of Regents of the University of Oklahoma expires Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Oklahoma
- Grant date
- Tue Apr 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K38/00, A61P, A61P15/08, A61P35/00